Current Research

 
Stock Quotes for Current Research top ^
  • Industry: Internet Content & Information
  • Sector: Technology
  • Stock Style: Small Core
  • Stock Type: Slow Growth
Sign-up for livc investment picks
  • Industry: Publishing
  • Sector: Consumer Cyclical
Sign-up for crtcf investment picks

 
Fund Quotes for Current Research top ^
  • Category: Intermediate Government
  • Morningstar Rating: 3 Stars
Sign-up for wcifx investment picks
  • Category: Money Market-Taxable
Sign-up for jccxx investment picks
  • Category: Money Market-Taxable
Sign-up for jcixx investment picks
  • Category: Short-Term Bond
Sign-up for jpcsx investment picks
  • Category: Short-Term Bond
Sign-up for jpcix investment picks
  • Category: Short-Term Bond
Sign-up for JPCIX investment picks
  • Category: Short-Term Bond
Sign-up for JPCSX investment picks
  • Category: Intermediate Government
  • Morningstar Rating: 3 Stars
Sign-up for WCIFX investment picks

 
News Articles for Current Research top ^
2014/5/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115482&ProfileId=051205&sourceType=1 MIAMI, FL --
Sign-up for Metrospaces Issues Fourth Letter to Shareholders With Overall Overview of the Company's Current Projects investment picks
http://media.marketwire.com/attachments/201005/596355_LogoHorzLG.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1117216&ProfileId=051205&sourceType=1 BEAVERTON, OR --
Sign-up for Cascade Microtech Expands Power Device Characterization Solution to Meet Ultra High-Voltage/High-Current Requirements investment picks
SUNNYVALE, Calif., May 6, 2014 (GLOBE NEWSWIRE) -- Alpha and Omega Semiconductor Limited (AOS) (Nasdaq:AOSL) , a designer, developer and global supplier of a broad range of power semiconductors and power ICs, today introduced AOZ1331 , the latest addition to the EZPower Smart Load Switch family that delivers up to 6A per channel of continuous current.
Sign-up for Photo Release -- Alpha and Omega Semiconductor Offers Dual-Channel EZPower(TM) Smart Load Switch Delivering up to 6A Per Channel of Continuous Current investment picks
http://media.marketwire.com/attachments/201404/74258_dynagas.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1107943&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for Dynagas LNG Partners L.P. Announces New 13-Year Time-Charter Contract for the Clean Force and Amendment of Current Contract Expiration Date investment picks
Optima HDx Tool of Record for Next-Gen High Dose, Low Energy Memory Process BEVERLY, Mass.
Sign-up for Multi-System Follow-On Order Received For Axcelis Optima HDx High Current Implanter investment picks
http://media.marketwire.com/attachments/201405/246681_SNBcolorHrzLgo326x148.bmp http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1113045&ProfileId=051205&sourceType=1 MONTEBELLO, NY --
Sign-up for New York Health Care Companies Looking to Expand Frustrated With Current Options for Raising Capital investment picks
2014/5/22
Aeterna Zentaris: Poster to be Presented on the Design of Current ZoptEC Phase 3 Trial in Endometrial Cancer with Zoptarelin Doxorubicin at ASCO Canada NewsWire Abstract TPS5630: " ZoptEC: Phase 3 study of zoptarelin doxorubicin (AEZS-108) in platinum-taxane pretreated endometrial cancer (Study AEZS-108-050) ", David S.
Sign-up for Aeterna Zentaris: Poster to be Presented on the Design of Current ZoptEC Phase 3 Trial in Endometrial Cancer with Zoptarelin Doxorubicin at ASCO investment picks
2014/4/21
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1108204&ProfileId=051205&sourceType=1 IRVINE, CA --
Sign-up for Emaji Files Annual Report to Regain Current Status on OTC Markets investment picks
2014/5/22
QUÉBEC CITY, May 22, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") today announced that a poster will be presented on the design of its current Z opt EC ( Zopt arelin doxorubicin in E ndometrial C ancer) Phase 3 trial in women with advanced, recurrent or metastatic endometrial cancer.
Sign-up for Aeterna Zentaris: Poster to be Presented on the Design of Current ZoptEC Phase 3 Trial in Endometrial Cancer with Zoptarelin Doxorubicin at ASCO investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Current Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Current Income  |  Next: Current Status